Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 May 30;6(4):e12735.
doi: 10.1002/rth2.12735. eCollection 2022 May.

Are outpatient anticoagulation management services the wave of the future (again)?

Bethany Samuelson Bannow  1
Affiliations

Are outpatient anticoagulation management services the wave of the future (again)?

Bethany Samuelson Bannow. Res Pract Thromb Haemost. .
No abstract available

Keywords: anticoagulant; apixaban; dabigatran; edoxaban; rivaroxaban.

PubMed Disclaimer

References

    1. Sylvester KW, Chen A, Lewin A, Fanikos J, Goldhaber SZ, Connors JM. Optimization of DOAC management services in a centralized anticoagulation clinic. Res Pract Thromb Haemost. 2022;6(3). doi: 10.1002/rth2.12696 - DOI - PMC - PubMed
    1. Mohammad I, Korkis B, Garwood CL. Incorporating comprehensive management of direct oral anticoagulants into anticoagulation clinics. Pharmacotherapy. 2017;37(10):1284‐1297. doi: 10.1002/phar.1991 - DOI - PubMed
    1. Sullivan PW, Arant TW, Ellis SL, Ulrich H. The cost effectiveness of anticoagulation management services for patients with atrial fibrillation and at high risk of stroke in the US. Pharmacoeconomics. 2006;24(10):1021‐1033. doi: 10.2165/00019053-200624100-00009 - DOI - PubMed
    1. Chua WB, Cheen HH, Kong MC, Chen LL, Wee HL. Modelling the cost‐effectiveness of pharmacist‐managed anticoagulation service for older adults with atrial fibrillation in Singapore. Int J Clin Pharm. 2016;38(5):1230‐1240. doi: 10.1007/s11096-016-0357-7 - DOI - PubMed
    1. Samama CM, Laporte S, Rosencher N, et al. Rivaroxaban or enoxaparin in nonmajor orthopedic surgery. N Engl J Med. 2020;382(20):1916‐1925. doi: 10.1056/nejmoa1913808 - DOI - PubMed